| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | Director | Common Shares | 25,053 | $211,197 | $8.43 | 21 Nov 2024 | Direct |
| Aurinia Pharmaceuticals Inc. | Director | Director Stock Option (right to buy) | 18,641 | 21 Nov 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | 21 Nov 2024 | 2 | $0 | 4 | Director | 25 Nov 2024, 16:36 |
| AUPH | Aurinia Pharmaceuticals Inc. | 21 May 2024 | 1 | -$32,201 | 4 | Director | 22 May 2024, 16:09 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2023 | 5 | -$54,217 | 4 | Director | 23 May 2023, 17:14 |
| AUPH | Aurinia Pharmaceuticals Inc. | 18 May 2022 | 2 | $0 | 4 | Director | 20 May 2022, 16:08 |
| AUPH | Aurinia Pharmaceuticals Inc. | 13 Dec 2021 | 1 | +$32,064 | 4 | Director | 15 Dec 2021, 15:09 |
| AUPH | Aurinia Pharmaceuticals Inc. | 14 Jun 2021 | 1 | $0 | 4 | Director | 16 Jun 2021, 21:16 |
| AUPH | Aurinia Pharmaceuticals Inc. | 11 May 2021 | 1 | +$27,389 | 4 | Director | 12 May 2021, 16:28 |